These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nefazodone (Serzone) withdrawn because of hepatotoxicity. Choi S CMAJ; 2003 Nov; 169(11):1187. PubMed ID: 14638657 [No Abstract] [Full Text] [Related]
5. The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. Khouzam HR J Psychosoc Nurs Ment Health Serv; 2000 Aug; 38(8):20-5. PubMed ID: 10959472 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of open-label nefazodone treatment in patients with panic disorder. Papp LA; Coplan JD; Martinez JM; de Jesus M; Gorman JM J Clin Psychopharmacol; 2000 Oct; 20(5):544-6. PubMed ID: 11001239 [TBL] [Abstract][Full Text] [Related]
8. Hepatic adverse reactions associated with nefazodone. Stewart DE Can J Psychiatry; 2002 May; 47(4):375-7. PubMed ID: 12025437 [TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease worsened by nefazodone. Benazzi F Int J Geriatr Psychiatry; 1997 Dec; 12(12):1195. PubMed ID: 9444544 [No Abstract] [Full Text] [Related]
11. Withdrawing drugs: nefazodone, the start of the latest saga. Edwards IR Lancet; 2003 Apr; 361(9365):1240. PubMed ID: 12699949 [No Abstract] [Full Text] [Related]
12. Nefazodone in social phobia. Van Ameringen M; Mancini C; Oakman JM J Clin Psychiatry; 1999 Feb; 60(2):96-100. PubMed ID: 10084635 [TBL] [Abstract][Full Text] [Related]